{
  "report_rows": [
    {
      "kpi": "Q2 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.98 vs. cons $1.93",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$2.24B vs. cons $2.20B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 organic sales growth",
      "prediction": "BEAT",
      "answer": "pred ~8.4% vs. cons 7.7%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$6.60 vs. cons $6.58 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 revenue including ERP reversal",
      "prediction": "LOWER",
      "answer": "guide ~$1.90B vs. cons $1.98B (Q3 2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Q3 adjusted EPS including ERP reversal",
      "prediction": "LOWER",
      "answer": "guide ~$1.31 vs. cons $1.44 (Q3 2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -3.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.8,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "The mechanical Q2 beat is likely outweighed by out-period revisions: implied Q3 adjusted EPS of ~$1.31 vs. consensus $1.44 and revenue of ~$1.90B vs. $1.98B should pull second-half estimates lower even if FY2026 EPS remains near ~$6.60 vs. consensus $6.58.",
  "day5_confidence": "MEDIUM"
}